Literature DB >> 17078011

Attitudes about stimulant medication for attention-deficit/hyperactivity disorder among African American families in an inner city community.

Susan dosReis1, Arlene Butz, Paul H Lipkin, Julia S Anixt, Courtney L Weiner, Robin Chernoff.   

Abstract

Limited information exists on views among African American families living in low-income, inner-city communities regarding the treatment of children with attention-deficit/hyperactivity disorder (ADHD). Parents of children treated for ADHD in an urban primary care setting were recruited to complete a survey to assess attitudes toward stimulant medications. Although most (71%) were initially hesitant to use stimulants based on what they heard in the lay press, 63% would recommend stimulant medication to a relative/friend whose child had ADHD. Approximately 17% believed stimulants led to drug abuse, 21% preferred counseling over medication, 21% felt medications had bad side effects, and 23% believed that too many children were medicated for ADHD. Most (90%) felt the medication was safe if a physician recommended it. Views did not differ between participants whose child had or had not received counseling. Additional studies are needed to clarify whether such views impact treatment choices and health outcomes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17078011     DOI: 10.1007/s11414-006-9038-y

Source DB:  PubMed          Journal:  J Behav Health Serv Res        ISSN: 1094-3412            Impact factor:   1.505


  24 in total

1.  Mental health services for youths in foster care and disabled youths.

Authors:  S dosReis; J M Zito; D J Safer; K L Soeken
Journal:  Am J Public Health       Date:  2001-07       Impact factor: 9.308

2.  Public attitudes toward the use of psychiatric medications for children.

Authors:  Jane D McLeod; Bernice A Pescosolido; David T Takeuchi; Terry Falkenberg White
Journal:  J Health Soc Behav       Date:  2004-03

3.  Effect of Medicaid eligibility category on racial disparities in the use of psychotropic medications among youths.

Authors:  Julie Magno Zito; Daniel J Safer; Ilene H Zuckerman; James F Gardner; Karen Soeken
Journal:  Psychiatr Serv       Date:  2005-02       Impact factor: 3.084

4.  Treatment of attention-deficit hyperactivity disorder by different physician specialties.

Authors:  D A Zarin; T L Tanielian; A P Suarez; S C Marcus
Journal:  Psychiatr Serv       Date:  1998-02       Impact factor: 3.084

5.  Mental health in the United States. Prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder--United States, 2003.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2005-09-02       Impact factor: 17.586

6.  Understanding urban child mental health l service use: two studies of child, family, and environmental correlates.

Authors:  M M McKay; J Pennington; C J Lynn; K McCadam
Journal:  J Behav Health Serv Res       Date:  2001-11       Impact factor: 1.505

7.  Fragmented care for inner-city minority children with attention-deficit/hyperactivity disorder.

Authors:  James P Guevara; Chris Feudtner; Daniel Romer; Thomas Power; Ricardo Eiraldi; Snejana Nihtianova; Aracely Rosales; Janet Ohene-Frempong; Donald F Schwarz
Journal:  Pediatrics       Date:  2005-10       Impact factor: 7.124

8.  Knowledge and information about ADHD: evidence of cultural differences among African-American and white parents.

Authors:  R Bussing; N E Schoenberg; A R Perwien
Journal:  Soc Sci Med       Date:  1998-04       Impact factor: 4.634

9.  Medicalization, ambivalence and social control: mothers' descriptions of educators and ADD/ADHD.

Authors:  Claudia Malacrida
Journal:  Health (London)       Date:  2004-01

10.  Who first suggests the diagnosis of attention-deficit/hyperactivity disorder?

Authors:  Leonard Sax; Kathleen J Kautz
Journal:  Ann Fam Med       Date:  2003 Sep-Oct       Impact factor: 5.166

View more
  16 in total

1.  Using Best-Worst Scaling to Measure Caregiver Preferences for Managing their Child's ADHD: A Pilot Study.

Authors:  Susan dosReis; Xinyi Ng; Emily Frosch; Gloria Reeves; Charles Cunningham; John F P Bridges
Journal:  Patient       Date:  2015-10       Impact factor: 3.883

2.  A best-worst scaling experiment to prioritize caregiver concerns about ADHD medication for children.

Authors:  Melissa Ross; John F P Bridges; Xinyi Ng; Lauren D Wagner; Emily Frosch; Gloria Reeves; Susan dosReis
Journal:  Psychiatr Serv       Date:  2014-11-17       Impact factor: 3.084

3.  Shared decision-making in pediatrics: a national perspective.

Authors:  Alexander G Fiks; A Russell Localio; Evaline A Alessandrini; David A Asch; James P Guevara
Journal:  Pediatrics       Date:  2010-07-12       Impact factor: 7.124

4.  Child problem recognition and help-seeking intentions among black and white parents.

Authors:  Idia B Thurston; Vicky Phares; Erica E Coates; Laura M Bogart
Journal:  J Clin Child Adolesc Psychol       Date:  2014-03-17

5.  Parent and Family Processes Related to ADHD Management in Ethnically Diverse Youth.

Authors:  Cynthia P Paidipati; Bridgette Brawner; Ricardo Eiraldi; Janet A Deatrick
Journal:  J Am Psychiatr Nurses Assoc       Date:  2017-01-11       Impact factor: 2.385

6.  Here/In This Issue and There/Abstract Thinking: Does This Answer Your Question?

Authors:  Cynthia E Rogers
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2017-10       Impact factor: 8.829

7.  A Latent Class Analysis to Identify Variation in Caregivers' Preferences for their Child's Attention-Deficit/Hyperactivity Disorder Treatment: Do Stated Preferences Match Current Treatment?

Authors:  Xinyi Ng; John F P Bridges; Melissa M Ross; Emily Frosch; Gloria Reeves; Charles E Cunningham; Susan dosReis
Journal:  Patient       Date:  2017-04       Impact factor: 3.883

8.  Caregivers' Priorities and Observed Outcomes of Attention-Deficit Hyperactivity Disorder Medication for Their Children.

Authors:  Melissa Ross; Vy Nguyen; John F P Bridges; Xinyi Ng; Gloria Reeves; Emily Frosch; Susan dosReis
Journal:  J Dev Behav Pediatr       Date:  2018 Feb/Mar       Impact factor: 2.225

9.  The impact of long-acting medications on attention-deficit/hyperactivity disorder treatment disparities.

Authors:  Brendan Saloner; Catherine Fullerton; Thomas McGuire
Journal:  J Child Adolesc Psychopharmacol       Date:  2013-08       Impact factor: 2.576

10.  The meaning of attention-deficit/hyperactivity disorder medication and parents' initiation and continuity of treatment for their child.

Authors:  Susan DosReis; Matthew P Mychailyszyn; Sara E Evans-Lacko; Alicia Beltran; Anne W Riley; Mary Anne Myers
Journal:  J Child Adolesc Psychopharmacol       Date:  2009-08       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.